Delivery Order SPE2DB22D3501-SPE2DB25FWF11
- Not listed
- The Defense Logistics Agency awarded a $2,495.69 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Menveo vaccine (1 vial A-C-Y-W-135-DIP 0.5ML), with completion scheduled for June 20, 2025. This competitive award carries no set-aside designation and utilizes firm fixed pricing under a delivery order contract type. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a $38,694 delivery order by the Defense Logistics Agency (DLA) on June 12, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This competitively awarded, firm fixed price contract carries no set-aside designation and has an ultimate completion date of June 13, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135-diphtheria), 0.5 mL. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,159.30 and is scheduled for completion by August 13, 2025. The award is issued under a non-set-aside procurement and represents a child contract action...
- The Defense Logistics Agency awarded a $326,442.90 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccines, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,007.16 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W vaccine kits (2 vials each). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 24, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $33,098.70 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine products, with a completion date of May 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a ceiling value of $18,340.29. This firm fixed-price delivery order, which must be completed by September 16, 2025, was awarded competitively with no set-aside designation. The award was issued from Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary place...
- The Defense Logistics Agency awarded a $42,163.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (A-C-Y-W-135-diphtheria) 0.5 mL vaccines with an ultimate completion date of July 30, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWF11Delivery Order
This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp $1,260.84 for the supply of Menveo vaccine (1 vial, formulation A-C-Y-W-135-DIP, 0.5ml) with completion targeted for June 30, 2025. The award utilizes firm fixed pricing under a non-set-aside, competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical federal vendor, fulfills orders across multiple therapeutic domains for customers including the Defense Health Agency and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/27/25 |